D2HGDH-mediated D2HG catabolism enhances the anti-tumor activities of CAR-T cells in an immunosuppressive microenvironment

The effect of immunotherapy is limited by oncometabolite D-2-hydroxyglutarate (D2HG). D2HGDH is an inducible enzyme that converts D2HG into the endogenous metabolite 2-oxoglutarate. We aimed to evaluate the impairment of CD8 T lymphocyte function in the high-D2HG environment and to explore the pheno...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Quanjun, Hao, Juan, Chi, Mengyi, Wang, Yaxian, Li, Jie, Huang, Jinlu, Zhang, Jianping, Zhang, Mengqi, Lu, Jin, Zhou, Shumin, Yuan, Ting, Shen, Zan, Zheng, Shuier, Guo, Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899596/
https://www.ncbi.nlm.nih.gov/pubmed/35007759
http://dx.doi.org/10.1016/j.ymthe.2022.01.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899596/
https://www.ncbi.nlm.nih.gov/pubmed/35007759
http://dx.doi.org/10.1016/j.ymthe.2022.01.007

Ejemplares similares